DALLAS, April 27, 2017 -- Texas Capital Bank today announced that Gary Ort, president of its highly successful Mortgage Finance Division, is retiring at the end of June and will be succeeded by Director of Correspondent Lending Jack Nunnery.
“Gary has been a key architect in the growth and success of Texas Capital Bank,” said Texas Capital Bank President and CEO Keith Cargill. “We owe him a tremendous amount of gratitude.”
Mr. Cargill continued, “Jack Nunnery has been at Gary’s side the whole way and brings to the role not only a deep knowledge of the business and its past but also a clear vision for its future. And both Gary and Jack understand the important role our clients have played in our success, and how Texas Capital Bank wouldn’t be here without them.”
Vince Ackerson, the bank’s Texas president and chief lending officer, said, “Our mortgage operation has achieved remarkable milestones thanks to Gary Ort. With Jack Nunnery at the helm, we expect Texas Capital Bank to show sustained leadership in this market.”
Under Mr. Ort, who served Texas Capital for the past decade, the bank built its Mortgage Warehouse unit into one of the largest providers of mortgage warehouse credit facilities in the country.
He also presided over the newly launched Correspondent Lending business and expanded Texas Capital Bank’s credit offering to mortgage lenders to include lines of credit secured by mortgage servicing rights, also one of the nation’s largest businesses of its kind.
“I’ve been privileged to be with an organization like Texas Capital Bank, which deeply values entrepreneurial thinking,” said Mr. Ort. “We’ve built a robust mortgage finance business, and I can’t think of a better person to grow it than Jack Nunnery.”
Mr. Nunnery has broad experience in the mortgage industry in a variety of roles, including counterparty risk management, mortgage technology, underwriting, post production and secondary marketing.
At Texas Capital Bank he oversaw the creation of the Correspondent Lending business, which launched in 2016, helping to introduce cutting edge technology and product innovation to the industry.
“Gary Ort has made a significant impact on Texas Capital Bank,” said Mr. Nunnery. “I am honored to take over the Mortgage Finance business and build on his success.”
ABOUT TEXAS CAPITAL BANK
Texas Capital Bank, N.A. is a commercial bank that delivers highly personalized financial services to businesses and entrepreneurs. We are headquartered in Texas working with clients throughout the state and across the country. Texas Capital Bank is a wholly owned subsidiary of Texas Capital Bancshares, Inc. (NASDAQ:TCBI) and is recognized as a Forbes Best Banks in America and the Dallas Morning News’ Top 100 Places To Work company. To find out why we’re the Best Business Bank in Texas®, please visit www.texascapitalbank.com. Member FDIC.
MEDIA CONTACT Emily Albrecht, 469.399.8599 [email protected]


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Washington Post Publisher Will Lewis Steps Down After Layoffs
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



